文献速递肝病

酒精性肝炎患者的胆汁酸稳态与肠道菌群失调

Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis.
PubMed 文献 · Aliment Pharmacol Ther · 2018-08-24

本研究为前瞻性研究,纳入108例活跃饮酒患者,按酒精性肝病严重程度分为四组,评估血浆和粪便胆汁酸谱及肠道菌群组成。发现肝硬化合并重度酒精性肝炎患者总胆汁酸和熊去氧胆酸升高、粪便总胆汁酸和次级胆汁酸降低,且菌群组成及15条代谢通路基因丰度改变,提示胆汁酸池向疏水毒性物种偏移与菌群改变可能形成恶性循环。

要点

  • 肝硬化合并重度酒精性肝炎患者血浆总胆汁酸84.6 vs 无严重酒精性肝炎的肝硬化患者6.8 μmol/L,P<0.001。
  • 同组患者粪便总胆汁酸2.4 vs 11.3,P=0.01;次级胆汁酸0.7 vs 10.7,P<0.01,均降低。
  • 该组菌群放线菌门丰度9% vs 1%(P=0.01),拟杆菌门25% vs 40%(P=0.04)。

核心结论

  • 肝硬化合并重度酒精性肝炎患者胆汁酸池向更疏水、毒性更强的物种偏移,可能驱动特定菌群变化;菌群也可通过将初级胆汁酸转化为次级胆汁酸而改变胆汁酸池,形成恶性循环。

研究设计与样本

  • 前瞻性研究,纳入108例活跃饮酒患者,分为四组:无肝硬化无酒精性肝炎(noCir_noAH,n=61)、无肝硬化有酒精性肝炎(noCir_AH,n=13)、肝硬化无严重酒精性肝炎(Cir_noAH,n=17)、肝硬化有重度酒精性肝炎(Cir_sAH,n=17)。
  • 评估血浆和粪便胆汁酸谱及肠道菌群组成。

主要发现

  • Cir_sAH患者血浆总胆汁酸84.6 vs Cir_noAH 6.8 μmol/L,P<0.001;血浆总熊去氧胆酸1.3 vs 0.3 μmol/L,P=0.03,均升高。
  • Cir_sAH患者粪便总胆汁酸2.4 vs Cir_noAH 11.3,P=0.01;粪便次级胆汁酸0.7 vs 10.7,P<0.01,均降低。
  • Cir_sAH患者菌群与Cir_noAH不同:放线菌门丰度9% vs 1%,P=0.01,升高;拟杆菌门丰度25% vs 40%,P=0.04,降低。
  • Cir_sAH患者菌群中涉及15条代谢通路的基因丰度改变,包括谷胱甘肽代谢上调、生物素代谢下调。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intestinal microbiota plays an important role in bile acid homeostasis. AIM: To study the structure of the intestinal microbiota and its function in bile acid homeostasis in alcoholic patients based on the severity of alcoholic liver disease. METHODS: In this prospective study, we included four groups of active alcoholic patients (N = 108): two noncirrhotic, with (noCir_AH, n = 13) or without alcoholic hepatitis (noCir_noAH, n = 61), and two cirrhotic, with (Cir_sAH, n = 17) or without severe alcoholic hepatitis (Cir_noAH, n = 17). Plasma and faecal bile acid profiles and intestinal microbiota composition were assessed. RESULTS: Plasma levels of total bile acids (84.6 vs 6.8 μmol/L, P < 0.001) and total ursodeoxycholic acid (1.3 vs 0.3 μmol/L, P = 0.03) were higher in cirrhosis with severe alcoholic hepatitis (Cir_sAH) than Cir_noAH, whereas total faecal (2.4 vs 11.3, P = 0.01) and secondary bile acids (0.7 vs 10.7, P < 0.01) levels were lower. Cir_sAH patients had a different microbiota than Cir_noAH patients: at the phyla level, the abundance of Actinobacteria (9 vs 1%, P = 0.01) was higher and that of Bacteroidetes was lower (25 vs 40%, P = 0.04). Moreover, the microbiota of Cir_sAH patients showed changes in the abundance of genes involved in 15 metabolic pathways, including upregulation of glutathione metabolism, and downregulation of biotin metabolism. CONCLUSIONS: Patients with Cir_sAH show specific changes of the bile acid pool with a shift towards more hydrophobic and toxic species that may be responsible for the specific microbiota changes. Conversely, the microbiota may also alter the bile acid pool by transforming primary to secondary bile acids, leading to a vicious cycle.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Ciocan D, Voican CS, Wrzosek L, et al. Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis. Aliment Pharmacol Ther. 2018. PMID: 30144108. doi:10.1111/apt.14949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。